T-cell dysregulation in COVID-19.
T-cell dysregulation in COVID-19.
复制标题
DOI:
10.1016/j.bbrc.2020.10.079
复制
发表时间:
2021-01-29
影响因子:
3.1
通讯作者:
Ono M
中科院分区:
文献类型:
--
作者:
Kalfaoglu B;Almeida-Santos J;Tye CA;Satou Y;Ono M
T-cells play key roles in immunity to COVID-19 as well as the development of severe disease. T-cell immunity to COVID-19 is mediated through differentiated CD4+ T-cells and cytotoxic CD8+ T-cells, although their differentiation is often atypical and ambiguous in COVID-19 and single cell dynamics of key genes need to be characterized. Notably, T-cells are dysregulated in severe COVID-19 patients, although their molecular features are still yet to be fully revealed. Importantly, it is not clear which T-cell activities are beneficial and protective and which ones can contribute to the development of severe COVID-19. In this article, we examine the latest evidence and discuss the key features of T-cell responses in COVID-19, showing how T-cells are dysregulated in severe COVID-19 patients. Particularly, we highlight the impairment of FOXP3 induction in CD4+ T-cells and how the impaired FOXP3 expression can lead to the differentiation of abnormally activated (hyperactivated) T-cells and the dysregulated T-cell responses in severe patients. Furthermore, we characterise the feature of hyperactivated T-cells, showing their potential contribution to T-cell dysregulation and immune-mediated tissue destruction (immunopathology) in COVID-19.
登录
查看更多内容
影响因子:
64.8
作者:
Bettelli, E;Carrier, YJ;Kuchroo, VK
通讯作者:
Kuchroo, VK
影响因子:
15.3
作者:
Geginat, J;Sallusto, F;Lanzavecchia, A
通讯作者:
Lanzavecchia, A
影响因子:
4.6
作者:
Bending D;Ono M
通讯作者:
Ono M
影响因子:
3.8
作者:
Assier, E;Jullien, V;Thèze, J
通讯作者:
Thèze, J
影响因子:
64.5
作者:
Bost, Pierre;Giladi, Amir;Amit, Ido
通讯作者:
Amit, Ido